(Q36415807)

14 August 2017

1 reference

title

Neurofibromatosis type 1: new insights into neurocognitive issues (English)

1 reference

14 August 2017

Alcino J Silva

3

0 references

author name string

Maria T Acosta

series ordinal

1

1 reference

PubMed ID

16522267

14 August 2017

Gerard A Gioia

series ordinal

2

1 reference

14 August 2017

1 March 2006

1 reference

Current Neurology and Neuroscience Reports

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

136-143

1 reference

14 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-996-0036-5

14 August 2017

0 references

cites work

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

1 reference

https://api.crossref.org/works/10.1007%2FS11910-996-0036-5

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-996-0036-5

Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-996-0036-5

Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-996-0036-5

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

21 January 2018

1 reference

12 December 2020

Treatment of ADHD in neurofibromatosis type 1.

1 reference

12 December 2020

Neuropsychological deficits in adults with neurofibromatosis type 1.

1 reference

12 December 2020

Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1.

1 reference

12 December 2020

Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

1 reference

12 December 2020

Neurocognitive dysfunction in children with neurofibromatosis type 1.

1 reference

12 December 2020

Neurofibromatosis: implications for learning and behavior.

1 reference

12 December 2020

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues

1 reference

12 December 2020

The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder

1 reference

12 December 2020

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

1 reference

12 December 2020

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.

1 reference

12 December 2020

Neurofibromin regulates G protein-stimulated adenylyl cyclase activity

1 reference

12 December 2020

Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1

1 reference

12 December 2020

Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.

1 reference

12 December 2020

Neurofibromatosis type 1

1 reference

12 December 2020

How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited.

1 reference

12 December 2020

The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes

1 reference

12 December 2020

A mouse model for the learning and memory deficits associated with neurofibromatosis type I

1 reference

12 December 2020

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

1 reference

12 December 2020

Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments.

1 reference

12 December 2020

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

1 reference

12 December 2020

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference

1 reference

12 December 2020

Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.

1 reference

12 December 2020

Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders

1 reference

12 December 2020

The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins

1 reference

12 December 2020

Cognitive impairment in neurofibromatosis type 1.

1 reference

12 December 2020

Intellectual impairment in neurofibromatosis 1.

1 reference

12 December 2020

Molecular genetics of human cognition

1 reference

12 December 2020

The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae

1 reference

12 December 2020

Neurofibromatosis type 1: the cognitive phenotype.

1 reference

12 December 2020

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group

1 reference

12 December 2020

Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons

1 reference

12 December 2020

Recent developments in the diagnosis and management of neurofibromatosis

1 reference

12 December 2020

Mouse models of neurofibromatosis type I: bridging the GAP.

1 reference

12 December 2020

Evaluation of genotype-phenotype correlations in neurofibromatosis type 1

1 reference

12 December 2020

Profiles of everyday executive function in acquired and developmental disorders.

1 reference

12 December 2020

Perspectives on farnesyl transferase inhibitors in cancer therapy

1 reference

12 December 2020

1 reference

12 December 2020

Cognitive function and academic performance in children with neurofibromatosis type 1.

1 reference

12 December 2020

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

1 reference

12 December 2020

Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders.

1 reference

12 December 2020

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila.

1 reference

12 December 2020

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

1 reference

12 December 2020

Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin

1 reference

12 December 2020

Math learning disability and math LD subtypes: evidence from studies of Turner syndrome, fragile X syndrome, and neurofibromatosis type 1.

1 reference

12 December 2020

Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD.

1 reference

12 December 2020

10.1007/S11910-996-0036-5

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16522267